BRENDA ORTIZ: Open Payments
NPI 1265263370 · NORTH LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,205 in 65 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $483 · 2025 $2,205
Food & beverage: $2,094Education: $111
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 12 | $419 |
| Alkermes, Inc. | 6 | $324 |
| Indivior Inc. | 5 | $248 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $247 |
| Otsuka America Pharmaceutical, Inc. | 7 | $245 |
| Teva Pharmaceuticals USA, Inc. | 5 | $171 |
| Axsome Therapeutics, Inc. | 2 | $147 |
| ABBVIE INC. | 7 | $137 |
| Almatica Pharma LLC | 4 | $98 |
| Lundbeck LLC | 4 | $66 |
Products named: COBENFY, SUBLOCADE, CAPLYTA, LYBALVI, Auvelity, VRAYLAR, REXULTI, ABILIFY MAINTENA.
Industry payments across NV — which companies pay providers there.
